Cargando…

Long-term effect of neoadjuvant radiotherapy in patients with locally advanced rectal mucinous adenocarcinoma: a population-based study of 1514 patients

Rectal mucinous adenocarcinoma (RMAC) is a rare and aggressive form of rectal cancer. The effectiveness of neoadjuvant radiotherapy (NRT) for RMAC has not been well studied, and the survival benefit remains controversial. The purpose of this work was to determine the prognostic role of NRT in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Can, Chen, Xi, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359247/ https://www.ncbi.nlm.nih.gov/pubmed/37474620 http://dx.doi.org/10.1038/s41598-023-38846-8

Ejemplares similares

Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study
por: Sun, Yan-wu, et al.
Publicado: (2017)

Locally advanced rectal mucinous adenocarcinoma: is preoperative radiation necessary?
por: Li, Biao, et al.
Publicado: (2022)

Vigo on Toothache, 1514
Publicado: (1899)

Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
por: Vernmark, Karolina, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy or radiotherapy in patients aged 75 years or older with locally advanced rectal cancer
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

Long-term Effect of Radiotherapy in Rectal Cancer Patients with Mucinous Tumor: A Large Population Based Study
por: Guan, Xu, et al.
Publicado: (2017)

Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram
por: Li, Zhihui, et al.
Publicado: (2021)

A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy
por: Cao, Wuteng, et al.
Publicado: (2020)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas
por: Yorio, Jeffrey T., et al.
Publicado: (2012)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
por: Wan, Xiang-Bo, et al.
Publicado: (2020)

Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
por: Delishaj, Durim, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally‐advanced rectal cancer
por: Hardiman, Karin M., et al.
Publicado: (2019)

Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer
por: Doi, Hiroshi, et al.
Publicado: (2021)

Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer
por: Kang, Min Kyu
Publicado: (2023)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
por: Tokuhara, Katsuji, et al.
Publicado: (2016)

Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
por: Tang, Jinghua, et al.
Publicado: (2018)

Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2022)

Efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective study
por: Xu, Yuyan, et al.
Publicado: (2023)

BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy
por: Liu, Hengchang, et al.
Publicado: (2020)

Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma
por: Peng, Haihua, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
por: Chin, Re-I, et al.
Publicado: (2022)

Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?
por: Yeo, Seung-Gu, et al.
Publicado: (2014)

Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study
por: Hiratsuka, Takahiro, et al.
Publicado: (2018)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma
por: Ferrando, Lorenzo, et al.
Publicado: (2020)

The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery
por: Vernmark, Karolina, et al.
Publicado: (2023)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
por: Song, Jianyuan, et al.
Publicado: (2020)

Intraoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Kang, Min Kyu, et al.
Publicado: (2010)

Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
por: Doi, Hiroshi, et al.
Publicado: (2013)

Typical CT and MRI Features of Mucinous Rectal Adenocarcinoma
por: Ryoo, Jin-A, et al.
Publicado: (2019)

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Kim, Eunji, et al.
Publicado: (2019)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma
por: Velandia, Carlos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2f0i1tuv4171puk4qnmkg9a967